CN109453225A - 一种富含维生素c中药提取物组合物和用途 - Google Patents
一种富含维生素c中药提取物组合物和用途 Download PDFInfo
- Publication number
- CN109453225A CN109453225A CN201811342104.5A CN201811342104A CN109453225A CN 109453225 A CN109453225 A CN 109453225A CN 201811342104 A CN201811342104 A CN 201811342104A CN 109453225 A CN109453225 A CN 109453225A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- chinese medicine
- traditional chinese
- rich
- hour
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 title claims abstract description 125
- 239000000284 extract Substances 0.000 title claims abstract description 61
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 title claims abstract description 60
- 229930003268 Vitamin C Natural products 0.000 title claims abstract description 60
- 235000019154 vitamin C Nutrition 0.000 title claims abstract description 60
- 239000011718 vitamin C Substances 0.000 title claims abstract description 60
- 239000003814 drug Substances 0.000 title claims abstract description 57
- 239000000203 mixture Substances 0.000 title claims abstract description 51
- 241000208340 Araliaceae Species 0.000 claims abstract description 23
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 23
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 23
- 235000008434 ginseng Nutrition 0.000 claims abstract description 23
- 239000009636 Huang Qi Substances 0.000 claims abstract description 22
- 239000002537 cosmetic Substances 0.000 claims abstract description 17
- 230000036541 health Effects 0.000 claims abstract description 17
- 239000003826 tablet Substances 0.000 claims abstract description 17
- 239000000654 additive Substances 0.000 claims abstract description 14
- 230000000996 additive effect Effects 0.000 claims abstract description 14
- 239000002775 capsule Substances 0.000 claims abstract description 14
- 238000000034 method Methods 0.000 claims abstract description 14
- 239000008187 granular material Substances 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 69
- 238000002386 leaching Methods 0.000 claims description 66
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 62
- 235000019441 ethanol Nutrition 0.000 claims description 39
- 150000001875 compounds Chemical class 0.000 claims description 28
- 238000002360 preparation method Methods 0.000 claims description 23
- 239000000463 material Substances 0.000 claims description 19
- 238000004064 recycling Methods 0.000 claims description 17
- 239000002131 composite material Substances 0.000 claims description 13
- 238000001035 drying Methods 0.000 claims description 13
- 230000005484 gravity Effects 0.000 claims description 13
- 230000001404 mediated effect Effects 0.000 claims description 13
- 239000004570 mortar (masonry) Substances 0.000 claims description 13
- 238000000605 extraction Methods 0.000 claims description 11
- 238000009835 boiling Methods 0.000 claims description 4
- 239000007938 effervescent tablet Substances 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 239000006189 buccal tablet Substances 0.000 claims description 3
- 229940046011 buccal tablet Drugs 0.000 claims description 3
- 239000007910 chewable tablet Substances 0.000 claims description 3
- 239000008280 blood Substances 0.000 abstract description 23
- 210000004369 blood Anatomy 0.000 abstract description 22
- 230000000694 effects Effects 0.000 abstract description 13
- 150000003254 radicals Chemical class 0.000 abstract description 11
- 239000008194 pharmaceutical composition Substances 0.000 abstract description 8
- 230000017531 blood circulation Effects 0.000 abstract description 7
- 210000003491 skin Anatomy 0.000 abstract description 7
- 239000003963 antioxidant agent Substances 0.000 abstract description 6
- 230000003078 antioxidant effect Effects 0.000 abstract description 6
- 235000006708 antioxidants Nutrition 0.000 abstract description 6
- 230000001737 promoting effect Effects 0.000 abstract description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 5
- 229940079593 drug Drugs 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 230000006378 damage Effects 0.000 abstract description 4
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 230000011712 cell development Effects 0.000 abstract description 3
- 230000003750 conditioning effect Effects 0.000 abstract description 3
- 230000002500 effect on skin Effects 0.000 abstract description 3
- 210000004927 skin cell Anatomy 0.000 abstract description 3
- 208000012641 Pigmentation disease Diseases 0.000 abstract description 2
- 241000130764 Tinea Species 0.000 abstract description 2
- 208000002474 Tinea Diseases 0.000 abstract description 2
- 230000019612 pigmentation Effects 0.000 abstract description 2
- 230000002265 prevention Effects 0.000 abstract description 2
- 208000028990 Skin injury Diseases 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 229940100688 oral solution Drugs 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 description 29
- 239000000243 solution Substances 0.000 description 20
- 229920000858 Cyclodextrin Polymers 0.000 description 18
- 239000001116 FEMA 4028 Substances 0.000 description 18
- 229960004853 betadex Drugs 0.000 description 18
- 239000000047 product Substances 0.000 description 17
- 230000007812 deficiency Effects 0.000 description 13
- 239000012141 concentrate Substances 0.000 description 9
- 239000000706 filtrate Substances 0.000 description 9
- 238000001914 filtration Methods 0.000 description 9
- 238000007654 immersion Methods 0.000 description 9
- 238000004904 shortening Methods 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 6
- 210000002216 heart Anatomy 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 230000008901 benefit Effects 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 208000037093 Menstruation Disturbances Diseases 0.000 description 2
- 206010027339 Menstruation irregular Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000002845 discoloration Methods 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 2
- 229940114124 ferulic acid Drugs 0.000 description 2
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 2
- 235000001785 ferulic acid Nutrition 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000002000 scavenging effect Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 206010002065 Anaemia megaloblastic Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 208000034657 Convalescence Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 208000000682 Megaloblastic Anemia Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000037354 amino acid metabolism Effects 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000004098 cellular respiration Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 238000002309 gasification Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 231100001016 megaloblastic anemia Toxicity 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- XKLJHFLUAHKGGU-UHFFFAOYSA-N nitrous amide Chemical compound ON=N XKLJHFLUAHKGGU-UHFFFAOYSA-N 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 230000033116 oxidation-reduction process Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000007348 radical reaction Methods 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 201000010727 rectal prolapse Diseases 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/738—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medical Informatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Nutrition Science (AREA)
- Birds (AREA)
- Food Science & Technology (AREA)
- Toxicology (AREA)
- Polymers & Plastics (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Biochemistry (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明涉及保健品加工领域,具体公开的一种富含维生素C中药提取物组合物,它是由以下配比原料制成:维生素C 0.5‑18g,人参150g,当归450g,川穹100g,黄芪550g。本发明利用维生素C具有抗氧化、清除自由基的有益效果,与具有益气化瘀,调经祛斑,滋养肌肤作用的中药组合,对防治自由基对肌肤的损伤,促进血液循环,增进肌肤细胞发育具有较好的辅助防治效果。通过维生素C与本发明中药组合的提取物组成新的药用组合物,强化了药物对皮肤损伤、色斑、癣疾病及皮肤色素沉着等具有良好的调理功能。所述的组合物按常规工艺制成片剂、胶囊剂、颗粒剂、口服液作为制备保健品的用途或作为制备化妆品中的添加剂的用途。
Description
技术领域
本发明涉及药物制剂和/或保健食品加工领域,具体涉及一种由维生素C和中药提取物组合物和用途。
背景技术
由于现代人们生活节奏加快,生活压力大,生活结构的变化,加之环境污染给现代生活中一些特有的疾病也相应的呈现增多趋势。如因气血不足,气血阻滞或气虚血瘀等所致的内分泌紊乱,黄褐斑(黧黑斑)、雀斑、蝴蝶斑,皮肤面黄粗糙等病例明显增加,直到目前也未有确切疗效的治疗药物。利用维生素C具有特殊的抗氧化和清除自由基作用的功效,结合我国传统的中医药理论,与具有益气化瘀,调经祛斑,滋养肌肤的中药组合,将维生素C这种活性物质与传统医学和现代制药工艺技术有机结合,组成一种新的药物组合物,使该组合物能在上述疾病的治疗中起到辅助的防治作用。
发明内容
本发明的目的在于提供一种富含维生素C中药提取物组合物。
本发明的目的还在于提供一种富含维生素C中药提取物组合物在制备辅助调节益气化瘀、调经祛斑、滋养肌肤药物中作为制备保健品的用途。
本发明的目的还在于提供一种富含维生素C中药提取物组合物在制备化妆品中的添加剂的用途。
本发明提供的一种富含维生素C中药提取物组合物,其特征在于,它是由以下配比原料制成:维生素C 0.5-18g,人参150g,当归450g,川穹100g,黄芪550g,
其制备方法如下:取人参150g,当归450g,川穹100g,黄芪550g加入药材重量比10倍浓度为75%v/v的乙醇,在38℃-40℃下浸泡168小时,滤取浸泡提取液,回收乙醇得浸提液保存备用,另将药渣分别按药材重量8倍、5倍、3倍加水煎煮提取3次,煎煮提取时间为第一次2小时,第二次1小时,第三次0.5小时,合并三次煎煮提取液,经过滤、浓缩至比重为1.0的浓缩液时,再与上述回收乙醇后的浸提液合并混匀,经干燥至含水量为4-5%,得中药提取物;另将维生素C按重量比为1:6.5比例和2-羟丙基-β-环糊精在乳钵内混合,加入适量的水进行捏合以形成一个均匀的糊剂,继续研磨40min,于42℃条件下干燥,所得干燥混合物用研棒研碎,过150μm筛,得维生素C-2-羟丙基-β-环糊精包合物,将包合物与上述中药提取物充分混合均匀,过180μm筛,即得富含维生素C中药提取物组合物。
本发明优选的一种富含维生素C中药提取物组合物,其特征在于,它是由以下配比的原料制成:维生素C 1.5-15g,人参150g,当归450g,川穹100g,黄芪550g。
本发明进一步优选的一种富含维生素C中药提取物组合物,其特征在于,它是由以下配比的原料制成:维生素C 3.5-10g,人参150g,当归450g,川穹100g,黄芪550g。
本发明中所述的水,在没有作出特定说明时,均为纯化水。
所述的药物组合物按常规工艺制成片剂、胶囊剂、颗粒剂作为制备保健品的用途。
所述的药物组合物作为制备化妆品中的添加剂的用途。
本发明所述的维生素C久置色变微黄,遇日光颜色可变深。遇空气或加热都易变质,保持维生素C的性质稳定成为医药、保健品、化妆品等行业的一个重要问题。
维生素C VitaminC(简称VC),别名抗坏血酸,丙种维生素,VC为白色结晶性粉末,味酸,无臭,久置色变微黄,遇日光颜色可变深。易溶于水。水溶液显酸性反应,不稳定,有还原性。遇空气或加热都易变质,在酸性溶液中比较稳定,在碱性溶液中易于氧化失效,氧化剂、光、热、核黄素及微量的铜、铁等能加速其失效。又本品与三氯叔丁醇配伍亦失效。
在体内抗坏血酸和脱氢抗坏血酸形成可逆的氧化还原系统,此系统在生物氧化及还原作用中和细胞呼吸中起重要作用。维生素C参与氨基酸代谢、神经递质的合成、胶原蛋白和组织细胞间质的合成。可降低毛细血管的通透性,加速血液的凝固,刺激凝血功能,促进铁在肠内吸收,促使血脂下降,增加对感染的抵抗力,参与解毒功能,且有抗组胺的作用及阻止致癌物质(亚硝胺)生成的作用。维生素C是一种很重要的自由基清除剂,能够有效地清除O2 -、H2O2、OH·和1O2等多种活性氧。
维生素C可用于延缓衰老,防止动脉粥样硬化和冠心病,放置坏血病、缺铁性贫血和巨幼细胞性贫血,还用于急慢性感染性疾病、外伤、术后恢复期、恶性肿瘤的辅助治疗,以及治疗紫癜、过敏性疾病等,此外,还用于过敏性皮肤病、口疮、促进伤口愈合等。
为了保护其维生素C的稳定性,本发明采取将维生素C与2-羟丙基-β-环糊精按重量为1:6.5的比例制成包合物,将本发明制得的维生素C-2-羟丙基-β-环糊精包合物与市售维生素C片相比较,对空气、湿、光、热稳定性有显著提高。由于维生素C被2-羟丙基-β-环糊精保护起来,维生素C不容易被氧化,因此比单纯使用维生素C稳定得多。
人参,甘,微苦,微温。归脾、肺、心肾经。具有大补元气,复脉固脱,补脾益肺,生津养血、安神益智功能。人参大补元气,元气充则心气得养,心神得宁,心智得聪,而具安神益智的功效,用于治疗心气不足或心肾气虚、心脾两虚的失眠、健忘等。人参甘温,大补元气,益气以生血,具气血双补之效,故可用治脾胃气虚,化源不足,血虚萎黄之证。
当归,甘、辛,温。归肝、心、脾经。具有补血活血,调经止痛,润肠通便功能,用于血虚萎黄,眩晕心悸,月经不调,经闭痛经,虚寒腹痛,风湿痹痛,跌扑损伤,痈疽疮疡,肠燥便秘。当归甘温,养血补虚,为补血良药,故可用治心肝血虚,血色萎黄,眩晕心悸。
川穹,辛,温。归肝、胆、心包经。具有活血行气,祛风止痛功能。川穹辛散温通,功能活血行气,有“血中气药”(《本草汇言》)之称。既活血祛瘀通脉,善治心脉瘀阻、胸痹心痛;又行气开郁止痛,为肝郁气滞之胸肋刺痛所多用。川穹善于“下调经水”(《本草汇言》)、活血调经,优为月经不调、痛经、经闭等证之要药;亦治癥瘕腹痛,具有活血祛瘀、消癥散结之功。
黄芪,甘,微温。归肺、脾经。具有补气升阳,固表止汗,利水消肿,生津养血,行滞通痹,托毒排脓,敛疮生肌功效,用于气血乏力,食少便溏,中气下陷,腹泻脱肛,便血崩漏,表虚自汗,气虚水肿,内热消渴,气虚萎黄之证。黄芪甘微温,益气升阳,盖阳生阴长,气旺血生,故有补气生血之功,长用于劳倦内伤,气亏血虚,血虚阳浮,肌热面赤,脉大无力之血虚发热证。及思虑过度,劳伤心脾,气血双亏,面色萎黄,心悸失眠者。
以上4种中药组成制备提取物,按照中医药理论证明具有益气化瘀,调经祛斑,滋养肌肤作用,按现代中药理论研究,如组份中当归为主药之一,其有效成分阿魏酸能减少H2O2含量,并与磷脂酰乙醇胺结合抑制氧化反应和自由基反应,拮抗自由基对组织的损害,促进血液循环,增进肌肤细胞发育的作用。阿魏酸不仅能淬灭自由基。而且还能调节人体生理机制,抑制产生自由基的酶,促进清除自由基的酶的产生。
利用维生素C活性成分与中药组合提取物能产生不同成分、不同作用机制的协同治疗作用,能强化其药物的抗氧化和清除自由基作用。本发明利用维生素C具有抗氧化、清除自由基的有益效果,与具有益气化瘀,调经祛斑,滋养肌肤作用的中药组合,对防治自由基对肌肤的损伤,促进血液循环,增进肌肤细胞发育具有较好的辅助防治效果。通过维生素C与本发明中药组合的提取物组成新的药用组合物,能够充分发挥维生素C成分和中药成分有益效果,特别是增加了维生素C具有的特殊抗氧化和清除自由基的功效,强化了药物对皮肤损伤、色斑、癣疾病及皮肤色素沉着等具有良好的调理功能,为本发明药物组合物在保健食品、化妆品中的应用提供了理论基础。尤其是抗氧化、清除自由基和身体机能调理功能更为显著,因此产品既可以作为保健食品内服食用,也可作为天然的美容护肤产品外用。本发明克服了目前中药组合成分功效不理想的问题,而且产品使用方便,口感较好,工艺简单,生产效率高,质量稳定,可广泛用于保健品、化妆品的生产。
本发明的一种药用组合物,可以根据需要配制成不同的口服剂型。可以将药用组合物与药学上可接受的辅料混合配制成片剂,胶囊剂,颗粒剂等,其中胶囊剂可制备成软胶囊剂和硬胶囊剂;其中片剂优选泡腾片,咀嚼片,口含片,因为泡腾片,咀嚼片,口含片与普通片剂相比有以下几点优势:(1)服用方便,可嚼服、含服,可化水,由于配制这些片剂都要加入一定量的糖份作为赋形剂,因而口感好,人们乐意服用,泡腾片加水自溶后犹如一杯饮料,使人们乐于饮用;(2)吸收快,因为经口腔或泡饮使药物成分离子化,使之吸收快,生物利用度高;(3)便于携带,方便运输。本发明一种药用组合物,还可以根据需要作为添加剂配制成化妆品。
具体实施方式
通过以下实施例是对本发明作进一步的说明,但对本发明的范围不构成任何限制。
实施例1
富含VC中药提取物组合物的制备
分别称取净药材人参150g,当归450g,川穹100g,黄芪550g,置于提取罐中,加入浓度为75%的乙醇12.5kg,在40℃条件下密闭浸泡168小时,浸泡期间每隔6小时进行搅拌1次,浸泡结束后,滤取浸泡提取液,将浸泡提取液回收乙醇得浸提液另器保存备用;将醇浸提后的药渣加入纯净水10公斤,加热煎煮2小时,滤取煎煮液,药渣再加入纯净水6.25公斤,加热煎煮1小时,滤取煎煮液,再将药渣加纯净水3.75公斤,加热煎煮0.5小时,滤取煎煮液,将3次煎煮液合并,过滤,将滤液浓缩至比重为1.0的浓缩液时,再与上述浸提液合并,再进一步浓缩成稠膏后,置于真空干燥机内进行真空干燥至含水量为4.5%,即得中药提取物;称取维生素C0.5g,置于乳钵内,加入3.25g2-羟基-β-环糊精混合并加入适量的水进行捏合以形成一个均匀的糊剂,继续研磨40min,于42℃条件下干燥,将所得干燥混合物用研棒研碎,过150μm筛,得维生素C-2-羟基-β-环糊精包合物,将包合物与上述中药提取物充分混合均匀,过180μm筛,即得。
所述的富含VC中药提取物组合物按常规工艺制成片剂、胶囊剂、颗粒剂作为制备保健品的用途或作为制备化妆品中的添加剂的用途。
实施例2
富含维生素C中药提取物组合物的制备
分别称取净药材人参150g,当归450g,川穹100g,黄芪550g,置于提取罐中,加入浓度为75%的乙醇12.5kg,在40℃条件下密闭浸泡168小时,浸泡期间每隔6小时进行搅拌1次,浸泡结束后,滤取浸泡提取液,将浸泡提取液回收乙醇得浸提液另器保存备用;将醇浸提后的药渣加入纯净水10公斤,加热煎煮2小时,滤取煎煮液,药渣再加入纯净水6.25公斤,加热煎煮1小时,滤取煎煮液,再将药渣加纯净水3.75公斤,加热煎煮0.5小时,滤取煎煮液,将3次煎煮液合并,过滤,将滤液浓缩至比重为1.0的浓缩液时,再与上述浸提液合并,再进一步浓缩成稠膏后,置于真空干燥机内进行真空干燥至含水量为4.5%,即得中药提取物;称取维生素C 15g,置于乳钵内,加入97.5g2-羟基-β-环糊精混合并加入适量的水进行捏合以形成一个均匀的糊剂,继续研磨40min,于42℃条件下干燥,将所得干燥混合物用研棒研碎,过150μm筛,得维生素C-2-羟基-β-环糊精包合物,将包合物与上述中药提取物充分混合均匀,过180μm筛,即得。
所述的富含VC中药提取物组合物按常规工艺制成片剂、胶囊剂、颗粒剂作为制备保健品的用途或作为制备化妆品中的添加剂的用途。
实施例3
富含维生素C中药提取物组合物的制备
分别称取净药材人参150g,当归450g,川穹100g,黄芪550g,置于提取罐中,加入浓度为75%的乙醇12.5kg,在40℃条件下密闭浸泡168小时,浸泡期间每隔6小时进行搅拌1次,浸泡结束后,滤取浸泡提取液,将浸泡提取液回收乙醇得浸提液另器保存备用;将醇浸提后的药渣加入纯净水10公斤,加热煎煮2小时,滤取煎煮液,药渣再加入纯净水6.25公斤,加热煎煮1小时,滤取煎煮液,再将药渣加纯净水3.75公斤,加热煎煮0.5小时,滤取煎煮液,将3次煎煮液合并,过滤,将滤液浓缩至比重为1.0的浓缩液时,再与上述浸提液合并,再进一步浓缩成稠膏后,置于真空干燥机内进行真空干燥至含水量为4.0%,即得中药提取物;称取维生素C 10g,置于乳钵内,加入65g2-羟基-β-环糊精混合并加入适量的水进行捏合以形成一个均匀的糊剂,继续研磨40min,于42℃条件下干燥,将所得干燥混合物用研棒研碎,过150μm筛,得维生素C-2-羟基-β-环糊精包合物,将包合物与上述中药提取物充分混合均匀,过180μm筛,即得。
所述的富含VC中药提取物组合物按常规工艺制成片剂、胶囊剂、颗粒剂作为制备保健品的用途或作为制备化妆品中的添加剂的用途。
实施例4
富含VC中药提取物组合物的制备
分别称取净药材人参150g,当归450g,川穹100g,黄芪550g,置于提取罐中,加入浓度为75%的乙醇12.5kg,在38℃条件下密闭浸泡168小时,浸泡期间每隔6小时进行搅拌1次,浸泡结束后,滤取浸泡提取液,将浸泡提取液回收乙醇得浸提液另器保存备用;将醇浸提后的药渣加入纯净水10公斤,加热煎煮2小时,滤取煎煮液,药渣再加入纯净水6.25公斤,加热煎煮1小时,滤取煎煮液,再将药渣加纯净水3.75公斤,加热煎煮0.5小时,滤取煎煮液,将3次煎煮液合并,过滤,将滤液浓缩至比重为1.0的浓缩液时,再与上述浸提液合并,再进一步浓缩成稠膏后,置于真空干燥机内进行真空干燥至含水量为4.8%,即得中药提取物;称取维生素C 3.5g,置于乳钵内,加入22.75g2-羟基-β-环糊精混合并加入适量的水进行捏合以形成一个均匀的糊剂,继续研磨40min,于42℃条件下干燥,将所得干燥混合物用研棒研碎,过150μm筛,得维生素C-2-羟基-β-环糊精包合物,将包合物与上述中药提取物充分混合均匀,过180μm筛,即得。
所述的富含VC中药提取物组合物按常规工艺制成片剂、胶囊剂、颗粒剂作为制备保健品的用途或作为制备化妆品中的添加剂的用途。
实施例5
富含VC中药提取物组合物的制备
分别称取净药材人参150g,当归450g,川穹100g,黄芪550g,置于提取罐中,加入浓度为75%的乙醇12.5kg,在38℃条件下密闭浸泡168小时,浸泡期间每隔6小时进行搅拌1次,浸泡结束后,滤取浸泡提取液,将浸泡提取液回收乙醇得浸提液另器保存备用;将醇浸提后的药渣加入纯净水10公斤,加热煎煮2小时,滤取煎煮液,药渣再加入纯净水6.25公斤,加热煎煮1小时,滤取煎煮液,再将药渣加纯净水3.75公斤,加热煎煮0.5小时,滤取煎煮液,将3次煎煮液合并,过滤,将滤液浓缩至比重为1.0的浓缩液时,再与上述浸提液合并,再进一步浓缩成稠膏后,置于真空干燥机内进行真空干燥至含水量为5.0%,即得中药提取物;称取维生素C 1.5g,置于乳钵内,加入9.75g2-羟基-β-环糊精混合并加入适量的水进行捏合以形成一个均匀的糊剂,继续研磨40min,于42℃条件下干燥,将所得干燥混合物用研棒研碎,过150μm筛,得维生素C-2-羟基-β-环糊精包合物,将包合物与上述中药提取物充分混合均匀,过180μm筛,即得。
所述的富含VC中药提取物组合物按常规工艺制成片剂、胶囊剂、颗粒剂作为制备保健品的用途或作为制备化妆品中的添加剂的用途。
实施例6
富含VC中药提取物组合物的制备
分别称取净药材人参150g,当归450g,川穹100g,黄芪550g,置于提取罐中,加入浓度为75%的乙醇12.5kg,在38℃条件下密闭浸泡168小时,浸泡期间每隔6小时进行搅拌1次,浸泡结束后,滤取浸泡提取液,将浸泡提取液回收乙醇得浸提液另器保存备用;将醇浸提后的药渣加入纯净水10公斤,加热煎煮2小时,滤取煎煮液,药渣再加入纯净水6.25公斤,加热煎煮1小时,滤取煎煮液,再将药渣加纯净水3.75公斤,加热煎煮0.5小时,滤取煎煮液,将3次煎煮液合并,过滤,将滤液浓缩至比重为1.0的浓缩液时,再与上述浸提液合并,再进一步浓缩成稠膏后,置于真空干燥机内进行真空干燥至含水量为5.0%,即得中药提取物;称取维生素C 18g,置于乳钵内,加入117g2-羟基-β-环糊精混合并加入适量的水进行捏合以形成一个均匀的糊剂,继续研磨40min,于42℃条件下干燥,将所得干燥混合物用研棒研碎,过150μm筛,得维生素C-2-羟基-β-环糊精包合物,将包合物与上述中药提取物充分混合均匀,过180μm筛,即得。
所述的富含VC中药提取物组合物按常规工艺制成片剂、胶囊剂、颗粒剂作为制备保健品的用途或作为制备化妆品中的添加剂的用途。
实施例7
富含VC中药提取物组合物的制备
分别称取净药材人参150g,当归450g,川穹100g,黄芪550g,置于提取罐中,加入浓度为75%的乙醇12.5kg,在42℃条件下密闭浸泡168小时,浸泡期间每隔6小时进行搅拌1次,浸泡结束后,滤取浸泡提取液,将浸泡提取液回收乙醇得浸提液另器保存备用;将醇浸提后的药渣加入纯净水10公斤,加热煎煮2小时,滤取煎煮液,药渣再加入纯净水6.25公斤,加热煎煮1小时,滤取煎煮液,再将药渣加纯净水3.75公斤,加热煎煮0.5小时,滤取煎煮液,将3次煎煮液合并,过滤,将滤液浓缩至比重为1.0的浓缩液时,再与上述浸提液合并,再进一步浓缩成稠膏后,置于真空干燥机内进行真空干燥至含水量为4.0%,即得中药提取物;称取维生素C 5g,置于乳钵内,加入32.5g2-羟基-β-环糊精混合并加入适量的水进行捏合以形成一个均匀的糊剂,继续研磨40min,于42℃条件下干燥,将所得干燥混合物用研棒研碎,过150μm筛,得维生素C-2-羟基-β-环糊精包合物,将包合物与上述中药提取物充分混合均匀,过180μm筛,即得。
所述的富含VC中药提取物组合物按常规工艺制成片剂、胶囊剂、颗粒剂作为制备保健品的用途或作为制备化妆品中的添加剂的用途。
实施例8
富含VC中药提取物组合物的制备
分别称取净药材人参150g,当归450g,川穹100g,黄芪550g,置于提取罐中,加入浓度为75%的乙醇12.5kg,在42℃条件下密闭浸泡168小时,浸泡期间每隔6小时进行搅拌1次,浸泡结束后,滤取浸泡提取液,将浸泡提取液回收乙醇得浸提液另器保存备用;将醇浸提后的药渣加入纯净水10公斤,加热煎煮2小时,滤取煎煮液,药渣再加入纯净水6.25公斤,加热煎煮1小时,滤取煎煮液,再将药渣加纯净水3.75公斤,加热煎煮0.5小时,滤取煎煮液,将3次煎煮液合并,过滤,将滤液浓缩至比重为1.0的浓缩液时,再与上述浸提液合并,再进一步浓缩成稠膏后,置于真空干燥机内进行真空干燥至含水量为4.5%,即得中药提取物;称取维生素C 7.5g,置于乳钵内,加入48.75g2-羟基-β-环糊精混合并加入适量的水进行捏合以形成一个均匀的糊剂,继续研磨40min,于42℃条件下干燥,将所得干燥混合物用研棒研碎,过150μm筛,得维生素C-2-羟基-β-环糊精包合物,将包合物与上述中药提取物充分混合均匀,过180μm筛,即得。
所述的富含VC中药提取物组合物按常规工艺制成片剂、胶囊剂、颗粒剂作为制备保健品的用途或作为制备化妆品中的添加剂的用途。
实施例9
富含VC中药提取物组合物的制备
分别称取净药材人参150g,当归450g,川穹100g,黄芪550g,置于提取罐中,加入浓度为75%的乙醇12.5kg,在42℃条件下密闭浸泡168小时,浸泡期间每隔6小时进行搅拌1次,浸泡结束后,滤取浸泡提取液,将浸泡提取液回收乙醇得浸提液另器保存备用;将醇浸提后的药渣加入纯净水10公斤,加热煎煮2小时,滤取煎煮液,药渣再加入纯净水6.25公斤,加热煎煮1小时,滤取煎煮液,再将药渣加纯净水3.75公斤,加热煎煮0.5小时,滤取煎煮液,将3次煎煮液合并,过滤,将滤液浓缩至比重为1.0的浓缩液时,再与上述浸提液合并,再进一步浓缩成稠膏后,置于真空干燥机内进行真空干燥至含水量为4.5%,即得中药提取物;称取维生素C 12.5g,置于乳钵内,加入81.25g2-羟基-β-环糊精混合并加入适量的水进行捏合以形成一个均匀的糊剂,继续研磨40min,于42℃条件下干燥,将所得干燥混合物用研棒研碎,过150μm筛,得维生素C-2-羟基-β-环糊精包合物,将包合物与上述中药提取物充分混合均匀,过180μm筛,即得。
所述的富含VC中药提取物组合物按常规工艺制成片剂、胶囊剂、颗粒剂作为制备保健品的用途或作为制备化妆品中的添加剂的用途。
Claims (6)
1.一种富含维生素C中药提取物组合物,其特征在于,它是由以下配比原料制成:维生素C 0.5-18g,人参150g,当归450g,川穹100g,黄芪550g,
其制备方法如下:取人参150g,当归450g,川穹100g,黄芪550g加入药材重量比10倍浓度为75%v/v的乙醇,在38℃-40℃下浸泡168小时,滤取浸泡提取液,回收乙醇得浸提液保存备用,另将药渣分别按药材重量8倍、5倍、3倍加水煎煮提取3次,煎煮提取时间为第一次2小时,第二次1小时,第三次0.5小时,合并三次煎煮提取液,经过滤、浓缩至比重为1.0的浓缩液时,再与上述回收乙醇后的浸提液合并混匀,经干燥至含水量为4-5%w/w,得中药提取物;另将维生素C按重量比为1:6.5比例和2-羟丙基-β-环糊精在乳钵内混合,加入适量的水进行捏合以形成一个均匀的糊剂,继续研磨40min,于42℃条件下干燥,所得干燥混合物用研棒研碎,过150μm筛,得维生素C-2-羟丙基-β-环糊精包合物,将包合物与上述中药提取物充分混合均匀,过180μm筛,即得富含维生素C中药提取物组合物。
2.一种富含维生素C中药提取物组合物,其特征在于,它是由以下配比的原料制成:维生素C 1.5-15g,人参150g,当归450g,川穹100g,黄芪550g,
其制备方法如下:取人参150g,当归450g,川穹100g,黄芪550g加入药材重量比10倍浓度为75%v/v的乙醇,在38℃-40℃下浸泡168小时,滤取浸泡提取液,回收乙醇得浸提液保存备用,另将药渣分别按药材重量8倍、5倍、3倍加水煎煮提取3次,煎煮提取时间为第一次2小时,第二次1小时,第三次0.5小时,合并三次煎煮提取液,经过滤、浓缩至比重为1.0的浓缩液时,再与上述回收乙醇后的浸提液合并混匀,经干燥至含水量为4-5%w/w,得中药提取物;另将维生素C按重量比为1:6.5比例和2-羟丙基-β-环糊精在乳钵内混合,加入适量的水进行捏合以形成一个均匀的糊剂,继续研磨40min,于42℃条件下干燥,所得干燥混合物用研棒研碎,过150μm筛,得维生素C-2-羟丙基-β-环糊精包合物,将包合物与上述中药提取物充分混合均匀,过180μm筛,即得富含维生素C中药提取物组合物。
3.一种富含维生素C中药提取物组合物,其特征在于,它是由以下配比的原料制成:维生素C 3.5-10g,人参150g,当归450g,川穹100g,黄芪550g,
其制备方法如下:取人参150g,当归450g,川穹100g,黄芪550g加入药材重量比10倍浓度为75%v/v的乙醇,在38℃-40℃下浸泡168小时,滤取浸泡提取液,回收乙醇得浸提液保存备用,另将药渣分别按药材重量8倍、5倍、3倍加水煎煮提取3次,煎煮提取时间为第一次2小时,第二次1小时,第三次0.5小时,合并三次煎煮提取液,经过滤、浓缩至比重为1.0的浓缩液时,再与上述回收乙醇后的浸提液合并混匀,经干燥至含水量为4-5%w/w,得中药提取物;另将维生素C按重量比为1:6.5比例和2-羟丙基-β-环糊精在乳钵内混合,加入适量的水进行捏合以形成一个均匀的糊剂,继续研磨40min,于42℃条件下干燥,所得干燥混合物用研棒研碎,过150μm筛,得维生素C-2-羟丙基-β-环糊精包合物,将包合物与上述中药提取物充分混合均匀,过180μm筛,即得富含维生素C中药提取物组合物。
4.如权利要求1-3所述的组合物按常规工艺制成片剂、胶囊剂、颗粒剂作为制备保健品的用途。
5.如权利要求1-3所述的组合物作为制备化妆品中的添加剂的用途。
6.根据权利要求4所述的组合物的用途,用于配制泡腾片、咀嚼片、口含片。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811342104.5A CN109453225A (zh) | 2018-11-12 | 2018-11-12 | 一种富含维生素c中药提取物组合物和用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811342104.5A CN109453225A (zh) | 2018-11-12 | 2018-11-12 | 一种富含维生素c中药提取物组合物和用途 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109453225A true CN109453225A (zh) | 2019-03-12 |
Family
ID=65610166
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811342104.5A Withdrawn CN109453225A (zh) | 2018-11-12 | 2018-11-12 | 一种富含维生素c中药提取物组合物和用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109453225A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111743843A (zh) * | 2019-03-29 | 2020-10-09 | 宝洁公司 | 用于处理皮肤季节性变化的方法及组合物 |
-
2018
- 2018-11-12 CN CN201811342104.5A patent/CN109453225A/zh not_active Withdrawn
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111743843A (zh) * | 2019-03-29 | 2020-10-09 | 宝洁公司 | 用于处理皮肤季节性变化的方法及组合物 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102895410A (zh) | 女用阿胶固元膏 | |
CN105342908A (zh) | 一种缓解皱纹的积雪草中药美容抗皱膏及其制备方法 | |
CN109223908A (zh) | 富含绿茶提取物和中药提取物的组合物和用途 | |
CN102640920B (zh) | 一种食品美容茶冲剂 | |
CN109453225A (zh) | 一种富含维生素c中药提取物组合物和用途 | |
CN109260320A (zh) | 一种茶多酚和中药提取物的组合物和用途 | |
CN109453266A (zh) | 一种绿茶提取物和中药提取物的组合物和用途 | |
CN108815015A (zh) | 一种眼膜及其生产工艺 | |
CN104940725A (zh) | 一种养血美容的铁皮石斛中药组合物及其制剂 | |
CN104707004A (zh) | 降血压的药物 | |
CN109276590A (zh) | 富含原花青素和中药提取物的组合物和用途 | |
CN109223855A (zh) | 一种富含维生素e中药提取物组合物和用途 | |
CN106344480A (zh) | 一种美白祛斑无毒副作用的中药面膜及其制备方法 | |
CN106074765A (zh) | 一种安神、助睡眠的中药组合物 | |
CN109364113A (zh) | 一种白藜芦醇和中药提取物的组合物和用途 | |
CN105796971A (zh) | 一种治疗脂肪肝的中药制剂及其制作方法 | |
CN109331089A (zh) | 富含茶多酚中药提取物的组合物和用途 | |
CN104906252A (zh) | 一种治疗头发花白的中药 | |
CN108714176A (zh) | 一种治疗头发花白的中药 | |
CN109453270A (zh) | 富含葡萄籽油中药提取物组合物和用途 | |
CN108815082A (zh) | 一种面膜及其生产工艺 | |
CN109453227A (zh) | 一种原花青素和中药提取物的组合物和用途 | |
CN109260253A (zh) | 富含山核桃油中药提取物组合物和用途 | |
CN109453222A (zh) | 一种富含银杏油中药提取物组合物和用途 | |
CN109125387A (zh) | 一种富含山核桃油中药提取物组合物和用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20190312 |